The Use of Molecular Profiling to Predict Survival after Chemotherapy for Diffuse Large-B-Cell LymphomaAndreas Rosenwald, Louis M. Staudt, Elaine M. Hurt et al.|New England Journal of Medicine|2002Cited by 3.9k
Prediction of Survival in Follicular Lymphoma Based on Molecular Features of Tumor-Infiltrating Immune CellsSandeep S. Davé, Louis M. Staudt, George W. Wright et al.|New England Journal of Medicine|2004Cited by 1.4k
Molecular Diagnosis of Primary Mediastinal B Cell Lymphoma Identifies a Clinically Favorable Subgroup of Diffuse Large B Cell Lymphoma Related to Hodgkin LymphomaAndreas Rosenwald, Louis M. Staudt, George W. Wright et al.|The Journal of Experimental Medicine|2003Cited by 1.1k
Concurrent Expression of MYC and BCL2 in Diffuse Large B-Cell Lymphoma Treated With Rituximab Plus Cyclophosphamide, Doxorubicin, Vincristine, and PrednisoneNathalie A. Johnson, Randy D. Gascoyne, Graham W. Slack et al.|Journal of Clinical Oncology|2012Cited by 971
The proliferation gene expression signature is a quantitative integrator of oncogenic events that predicts survival in mantle cell lymphomaAndreas Rosenwald, Louis M. Staudt, George W. Wright et al.|Cancer Cell|2003Cited by 927